106
Cordlife Group Limited
Annual Report 2016
Notes to
The Financial Statements
for the financial year ended 30 June 2016
34. Investment in subsidiaries (cont’d)
Summarised financial information about subsidiary with material NCI
Summarised financial information including goodwill on acquisition and consolidation adjustments but before
intercompany eliminations of subsidiary with material non-controlling interests are as follows:
Cordlife
Sciences
Stemlife
(India) Pvt.
Berhad
Ltd.
2016
2015
$’000
$’000
Summarised statement of financial position
Current
Assets
Liabilities
27,600
(13,223)
7,605
(4,746)
Net current assets
14,377
2,859
Non-current
Assets
Liabilities
18,006
(3,933)
2,669
(3,075)
Net non-current assets/(liabilities)
14,073
(406)
Net assets
28,450
2,453
Summarised statement of comprehensive income
Revenue
3,456
12,588
Loss before income tax
Income tax credit
(272)
15
(1,679)
–
Loss for the year, representing total comprehensive loss for the year
(257)
(1,679)
Other financial information
Net cash flows generated from/(used in) operations
214
(2,903)
Acquisition of significant property, plant and equipment
217
861
35. Employee benefits expense
2016
$’000
Group
2015
$’000
Salaries, bonuses and other short-term benefits
17,513
14,559
Central Provident Fund contributions
1,222
919
Share-based compensation expense (Cordlife Share Grant Plan)
102
108
18,837
15,586
These include the amount shown as key management personnel compensation in Note 36(b).
